现代全髋关节置换30年生存率:系统综述、荟萃分析与全球关节登记数据外推
现代轴承技术显著改善了长期耐久性,可能影响患者咨询、医疗规划和器械监管。
要点
- 现代全髋关节置换预测30年生存率约92%,长期耐久性良好。
- 轴承表面技术进步可能影响患者咨询、医疗规划与器械监管。
核心结论
- 现代全髋关节置换的估计30年生存率约为92%,表明轴承表面技术进步大幅提高了长期耐久性。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Embase至2024年6月13日,纳入报告至少10年生存率的研究。
- 使用多变量随机效应模型外推登记数据至30年,主要结局为全因翻修生存率。
关键数值与推荐
- 现代轴承表面包括高交联聚乙烯对金属或第三/四代陶瓷头,以及陶瓷对陶瓷全髋关节置换。
- 纳入标准为报告至少10年生存率,不限固定方式或手术入路。
临床怎么用
- 现代全髋关节置换的长期生存数据可用于患者咨询,告知预期假体寿命。
- 医疗规划与资源分配可参考30年生存率约92%的预测。
- 器械监管决策可考虑现代轴承技术改善长期耐久性的证据。
局限性
- 30年生存率为基于登记数据的外推预测,非直接观察数据。
- 研究聚焦现代轴承表面,未涵盖所有全髋关节置换类型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total hip replacement is a successful operation that aims to restore function and quality of life to millions of people globally. Knowing how long a total hip replacement might last is important for patients, surgeons, and health-care institutions for planning and resource allocation. Over the past 20 years, the use of contemporary bearing surfaces for total hip replacement has substantially altered implant wear and, possibly, longevity. To date, there has been no large-scale study that examines survivorship of these modern implants. We aimed to determine the survivorship of contemporary total hip replacements and bearing materials. METHODS: We focused solely on the assessment of modern bearing surfaces: highly cross-linked polyethylene versus metal or third-generation and fourth-generation ceramic heads and ceramic-on-ceramic primary total hip replacement in adult patients. We conducted a search of MEDLINE and Embase from database inception to June 13, 2024, including articles that reported a minimum of 10 years of survivorship, irrespective of fixation method or surgical approach. We then conducted a meta-analysis combining data from eight national joint registries assessing all-cause revision within the various bearing combinations. We extrapolated the extracted data to estimate survivorship to 30 years, using the multivariable random-effects model from the registry data. The primary outcome was survivorship of the hip replacement, defined as time from primary total hip replacement to first all-cause revision, expressed as a percentage of unrevised implants at specific timepoints. This study is registered with PROSPERO (CRD42024572518). FINDINGS: We identified 1 904 237 total hip arthroplasties across 29 clinical studies (n=5203) and eight national joint registries (n=1 899 034). Pooled analysis of the included studies showed an all-cause implant survivorship of 0·97 (0·96-0·98) under the random-effects model. Survivorship estimate based on joint registry data was at 93·6% (95% CI 92·3-94·7) at 20 years. Extrapolating these data indicates a predicted survivorship of 92·8% (91·2-94·2) at 25 years and 92·1% (90·1- 93·7) at 30 years. INTERPRETATION: The estimated 92% 30-year survivorship of contemporary total hip replacement suggests that advances in bearing surface technology have greatly improved the long-term durability of total hip replacements and might influence patient counselling, health-care planning, and device regulation. FUNDING: None.
引用
- Pentland V, Thompson Z, Dayimu A, et al. Survivorship of modern total hip replacement to 30 years: systematic review, meta-analysis, and extrapolation of global joint registry data. Lancet. 2026. PMID: 41763743. doi:10.1016/S0140-6736(25)02305-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。